Saudi Arabia health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
January 2025 — Vol. 2, No. 1
Page 2 of 4 of this archive, newest first.
Also filed — page 2
the rolling newsroom, January 2025SGN declines, for the 17th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
STEP 3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Japan caps semaglutide prescribing to 13 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at SGN in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new France guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Japan health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
GL Biochem declines, for the 14th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A shortage listing ends. 17 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
TFC declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a WWB mazdutide lot at 98.5%, against 97.3% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
From the floor in Hong Kong: 14 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Medutest result on a Wuxi dulaglutide lot lands 2.0 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to the Netherlands after 6 consecutive customs detentions
The route did not close because of a rule about peptides.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
The relabeller trading as Vantris Bio closes after 16 years
A proper account of an operation that existed, and of what closing it cost.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
What a 32% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
The consolidator trading as Meridian Freight Partners closes after 23 years
A proper account of an operation that existed, and of what closing it cost.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 41% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
A shortage listing ends. 18 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
New Zealand health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
SUSTAIN-6 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What the new the Netherlands guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
ERP declines, for the 3rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a SSA survodutide lot at 97.1%, against 96.4% on the certificate
The result is unremarkable. What the report omits is not.